Biotech / Medical
Orthologic - beautiful chart OLGC
An SI Board Since February 2000
Posts SubjectMarks Bans
15 1 0
Emcee:  Pierre Borczuk Type:  Unmoderated
OrthoLogic Corp. develops, manufactures and markets proprietary, technologically advanced orthopedic products and packaged services for the orthopedic health care market including bone growth stimulation devices, continuous passive motion (CPM) devices and ancillary orthopedic recovery products and a therapeutic injectable for relief of pain from osteoarthritis of the knee. OrthoLogic's products are designed to enhance the healing of diseased, damaged, degenerated or recently repaired musculoskeletal tissue. The Company's products focus on improving the clinical outcomes and cost-effectiveness of orthopedic procedures that are characterized by compromised healing, high-cost, potential for complication and long recuperation time

Orthologic has based under 3 for many months and recently broke out, now making higher highs and higher lows , showing strength since Phase1/2 Chysalin news

Jan. 12, 2000--OrthoLogic Corp. (Nasdaq:OLGC - news) today announced that the company has begun enrolling patients in the combined Phase I/II clinical trial for Chrysalin.

Chrysalin is a synthetically manufactured peptide that has shown outstanding potential in preclinical animal studies to accelerate fracture healing.

Chrysalin represents a portion of the receptor-binding domain of the human thrombin molecule, which is actively involved in the healing process for both soft tissue and bone. By mimicking specific attributes of the thrombin molecule, Chrysalin stimulates the body's natural healing processes, resulting in accelerated tissue repair.

About the Trial

The trial consists of a prospective, randomized double-blind study of 90 patients in three clinical centers to evaluate the safety and preliminary efficacy of Chrysalin. Patients will receive one injection of Chrysalin or placebo (saline solution) at the time the fracture is set and will be monitored weekly to evaluate healing.
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
15Earnings call Jan 24th. Any opinions out there? OLGC presented at the JP MorganThure Meyer-1/14/2002
14 looks like selling into this news, chart a little worrisome...we need to keep mPierre Borczuk-3/18/2000
13 Remarkably little response to an impressive clinical study. If it works this wemortwald-3/17/2000
12 Chrysalin Shown to Accelerate Fracture Healing in Pre-Clinical Animal Studies SPierre Borczuk-3/15/2000
11 This may be an opportunity to munch on a little OLGC PierrePierre Borczuk-3/7/2000
10 AJ Hot sector, + chart already indicated acculmulation by someone Now it is lPierre Borczuk-2/29/2000
9 Hi Pierre, I'm also at a loss to explain yesterday's 33% gain. Since AJ Weissman-2/19/2000
8 OLGC ....nice move today 52 week high in making Again it just aPierre Borczuk-2/18/2000
7 Pierre, I am a long term, buy-and-hold type. My stops would be set much lower EL KABONG!!!-2/10/2000
6 Thanks Kerry ... Sounds like investors were trapped in this one for a while. Pierre Borczuk-2/10/2000
5 Hello Pierre, Okay, I looked it up for you... Use the archivesEL KABONG!!!-2/10/2000
4 If a tree falls and there is no one to hear it does it make a noise? If there Pierre Borczuk-2/10/2000
3 Hi Pierre, You may have to dig a bit to find the old news, but a few years agoEL KABONG!!!-2/9/2000
2 Hi Pierre, I found my way to OLGC through my personal experience with CPM deviAJ Weissman-2/8/2000
1 Seems like the strategy is to buy any the big boyes must be doing Pierre Borczuk-2/8/2000
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
Copyright © 1995-2018 Knight Sac Media. All rights reserved.Stock quotes are delayed at least 15 minutes - See Terms of Use.